プロフェッサー ドクター エドゥアルド・ベヒトはドイツで41年の経験を持つ泌尿器科医であり、アテネのカポディアストリアス大学から名誉博士号を授与されています。彼の主なポイントは以下の通りです:
Parkinson's Disease Diagnosis and Treatments
Alzheimer's Diagnosis and Treatments
Epilepsy (Epileptic)
EEG and Treatment
Muscle and Nerve Disease Diagnosis and Treatments
Vertigo Diagnosis and Treatment
Restless Leg Syndrome
Stroke (Cerebral Palsy) Diagnosis and Treatment
Bartın State Hospital (2007-2009)
VM Medical Park Samsun Hospital (2009-2017)
VM Medical Park Samsun Hospital - Deputy Chief Physician (2019-2021)
Samsun Education and Research Hospital (2021-2022)
Çarşamba State Hospital
Private Atasam Samsun Hospital (2022-2024)
Karadeniz Technical University (1989-1995)
Ondokuz Mayis University Faculty of Medicine (2001-2006)
Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.
Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Professional experience
2007. Director of the Assisted Reproduction Unit of the Quironsalud University Hospital of Madrid since its opening.
2004-06 Private consultation on assisted reproduction in Madrid.
1994-96. Deputy Physician. Department of Gynecology and Obstetrics. Hospital 12 de Octubre, Madrid.
Membership in scientific societies
-He is a member of the Spanish Society of Gynecology and Obstetrics (SEGO).
-Spanish Society of Fertility (SEF);
-European Society of Human Reproduction (ESHRE)
-American Society for Reproductive Medicine (ASRM).
Research and Teaching
In recent years, he has conducted over 30 conferences, 20 presentations and 15 talks at courses and conferences in his specialty. He has written 5 book chapters and coordinated 4 monographs.
2010 Associate Professor. European University of Madrid.
2004-07 Professor of Master in Human Reproduction. Spanish Fertility Society and Complutense University.
1990-98 Professor, PhD student. Training Center for Medical Specialists (CTO)
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.
His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.
He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Dr. Thanit Tundamrongpong is a board-certified physiatrist (Diplomate, Thai Board of Rehabilitation Medicine, 2024). He practices at Phra Nakhon Si Ayutthaya Hospital (2024–present) and lectures in rehabilitation medicine.
Expertise includes neurorehabilitation and stroke recovery; geriatric rehabilitation and active aging; chronic pain; robotic and exoskeleton gait training; ultrasound-guided interventions and hydrodissection; and advanced laser and radiofrequency therapies. Clinics: Modality, Musculoskeletal Pain, Diabetic Foot, EMG (electromyography), and interdisciplinary care.
Education: M.D., Thammasat University, 2018. Residency in Rehabilitation Medicine, Chulalongkorn University, 2024. Training: AOCNR 2023; Practical Spasticity; TASP Pain Management; Advanced Imaging and Ultrasound-Guided Toxin Injection Strategies.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.
He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.
Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.
Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.
He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.
He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.
Department of Gynecology
YEJI LEE
Medical Specialization YÜZÜNCÜ YIL UNIVERSITY
FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICINE/DEPARTMENT OF PEDIATRICS
2/Feb/2009
Name of Thesis: Screening for hematuria and proteinuria in school age children (2008) Supervisor:(ŞÜKRÜ ARSLAN)
Undergraduate Education SELÇUK UNIVERSITY
1997 MERAM FACULTY OF MEDICINE /MERAM MEDICAL PRACTICE.
30/June/ 2003
PROFESSOR ISTANBUL MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES
2019
/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)
ASSOCIATE PROFESSOR MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES
2014/-2019
/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)
ASSOCIATE PROFESSOR DÜZCE UNIVERSITY/FACULTY OF MEDICINE
2014/-2014
FACULTY MEMBER DUZCE UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL
2010/-2013
Supervised Theses
Medical Specialization
2022
MEDICAL SCIENCES/DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)
Cemalettin Güne , (2013). Investigation of Bone Metabolism Changes in Children with Type 1 Diabetes Mellitus,
DEPARTMENT OF CHILD HEALTH AND DISEASES/
Chief Physician ISTANBUL MEDIPOL UNIVERSITY/HEALTHCARE PRACTICE AND RESEARCH CENTER
2021
Birlikteli i: A case study Konuralp Tip Dergisi, 5(3), 58-61.
2009-2010 Specialist Doctor VAN GYNAECOLOGY AND PEDIATRIC HOSPITAL (State)
EDUCATION:
2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY
2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES
2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases
2004 DICLE UNIVERSITY, FACULTY OF MEDICINE
EXPERIENCE:
2018 Istanbul Medipol Hospital
2017 - 2018 Kartal Education and Research Hospital
2014 - 2016 Denizli State Hospital
2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital
2006 - 2011 Izmir Tepecik Education and Research Hospital
2011Izmir Education and Research Hospital
Dr. Sirinda “Ning” Kittiprachakul is a board-certified physiatrist (Thai Board of Rehabilitation Medicine, 2025) at King Chulalongkorn Memorial Hospital. She focuses on neurorehabilitation and cardiac rehabilitation. Her expertise includes geriatric rehabilitation, chronic pain management using Western dry needling, and electrodiagnostic and electromyographic studies.
She earned her MD with First Class Honors in 2020 and completed her Rehabilitation Medicine residency in 2025. She is a Ph.D. candidate in Clinical Sciences at Chulalongkorn University. Her research includes authorship in JACC (2019) and an abstract in Gut (IDDF 2025). She trained at KNRC in Korea in 2024. She received the MDCU Congress 2023 E‑poster consolation prize. She also completed training in HMS telemedicine, Nature Masterclasses, and focused shockwave therapy.
Dr. Tara Rak-areekul is a neurologist focused on cognitive neurology. She is a fellow at King Chulalongkorn Memorial Hospital. She completed her neurology residency there and served as Chief of Academic in 2023. She holds an MD from Chulalongkorn University (Second Class Honors) and a Higher Graduate Diploma in Clinical Sciences. She is certified in NIHSS (2022) and the Thai Stroke Society Acute Stroke Treatment Course.
Key achievements include first rank in the National Formative Neurological Exam (2023). She won the Epilepsy Quiz Tournament (2023). She was first runner-up at the Neurology Tournaments at NST Midyear 2023 and the Chula Neuroscience Forum 2022. Her research includes AAIC poster presentations (2024, 2025). Ongoing work covers Alzheimer’s biomarkers (MDS‑OAβ and p‑tau217), the Thai clinical adaptation of HippoCamera, and a chapter on behavioral and psychological symptoms of dementia (BPSD).
Education
Major degree in Medicine and Surgery (MBBS) Medical School University of Perugia, Italy. (2000-2006)
Internship at the Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2005 – 2006)
Clinical registration for Medicine and Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2006 – 2007)
Completion of the Italian Board Exams for the Medical and Surgical profession (Esame di Stato). Marks 262.5 / 270. Medical School University of Perugia, Italy. (June 2007)
Certificate of Completion of Training (CCT) in Cardiac Surgery. Marks 50/50. Thesis: “Trans-catheter Aortic Valve Implantation (TAVI) – A single centre experience”. Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (July 2014)
Training and Professional Experience
Junior Clinical Fellow in Cardiac Surgery, Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2007 – 2008)
Clinical Fellow in Cardiac Surgery, Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2008 – 2009)
Resident in Cardiac Surgery (CTh), Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2009 – 2014)
Cardiac Surgery Trainees Representative and Member of the Board of the School of Cardiac Surgery. “San Matteo” University Hospital, Pavia, Italy. (2011 – 2014)
Fellowship in Heart Transplant, Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (2011 – 2012)
Fellowship in Trans-catheter Aortic Valve Implantation (TAVI), Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)
Chief Resident in Cardiac Surgery, Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)
Fellowship in Adult Cardiac Surgery, Department of Cardio-thoracic Surgery, St. Georges University Hospital, London, UK. (2014 – 2015)
Senior Specialty doctor in Cardiac Surgery, Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2015 – 2022)
Lead of Trust Appointed Doctors to the SCTS for the Cardio-thoracic Unit, Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2020 – 2022)
Director of the Cardiac Surgery Unit, German Medical Institute, Limassol, Cyprus. (2022 – present)
Scientific Activity
MD: Thesis: “The importance of the surgical timing on post-operative outcome in patients with acute endocarditis of native valve”. Medical School University of Perugia, Italy. (April 2005 – December 2006)
Collaborator at the multi-centre National project “Effects of Covid-19 Pandemic on the Provision of Cardiac Surgery in the UK”. Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2020 – 2022)
Co-investigator at the COMICs multi-centre International Randomised Controlled Trial (RCT) comparing Mini-Bypass (MIECC) with conventional bypass. Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2018 – 2022)
Co-investigator at the ROUTE multi-centre international registry, aimed to analyse the effectiveness and safety of Transaortic (TAo)-TAVI as a first line approach and to compare it to patients receiving TAo-TAVI as a last resort, which is current practice. Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)
Special Interest
Myocardial revascularisation (coronary by-pass surgery with MIECC)
Aortic surgery (thoracic aorta aneurysm repair)
Aortic valve replacement or repair (minimal invasive, TAVI)
Mitral valve surgery (replacement or repair)
Heart transplant
Memberships
Founder member of the Cypriot Society of Cardiothoracic surgeons (CSCTS) founded in 2023.
Member of the European Association for Cardiothoracic Surgery (EACTS)
Member of the Society for Cardiothoracic Surgery (SCTS) in Great Britain and Ireland
Registration at the Cypriot Ministry of Health as Specialist in Cardiac Surgery (2016)
GMC-UK Specialist Register: Cardiothoracic Surgery (2014)
Italian Medical Council (Ordine dei Medici-Chirurghi): Full Registration with Licence to practise (2008 – 2014)